Literature DB >> 9619646

Late onset immunodeficiency in a patient with recurrent thymic carcinoma and myasthenia gravis.

S Schmidt1, F Padberg.   

Abstract

The most common autoimmune disease associated with thymoma is myasthenia gravis. In addition, cellular and humoral immune defects have been frequently reported in association with thymic neoplasms. Here we report the case of a patient with myasthenia gravis receiving long-term immunosuppression with azathioprine and recurrent well-differentiated thymic carcinoma who developed CD4+ T-cell depletion and CNS cryptococcosis after multiple courses of chemotherapy and mediastinal irradiation. We hypothesize that in thymectomized patients bone marrow suppression and abrogation of the peripheral T-cell pool can result in a delayed T-cell regeneration due to the lack of functional thymic epithelium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619646     DOI: 10.1016/s0022-510x(98)00085-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Good's syndrome and pure white cell aplasia complicated by cryptococcus infection: A case report and review of the literature.

Authors:  K Akinosoglou; M Melachrinou; D Siagris; E Koletsis; M Marangos; C A Gogos; E E Solomou
Journal:  J Clin Immunol       Date:  2014-03-14       Impact factor: 8.317

Review 2.  Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravis.

Authors:  Ernestina Santos; Ana Martins Silva; Philipp Stroebel; Antonio Marinho; Nick Willcox; Guilherme Goncalves; Carlos Lopes; Alexander Marx; Maria Isabel Leite
Journal:  Neurol Clin Pract       Date:  2019-02

3.  Progressive cutaneous Cryptococcosis complicated with meningitis in a myasthenia gravis patient on long-term immunosuppressive therapy - a case report.

Authors:  Nguyen Thi Cam Huong; Ahmed M A Altibi; Nguyen My Hoa; Le Anh Tuan; Samar Salman; Sara Morsy; Nguyen Thi Bich Lien; Nguyen Thanh Truong; Nguyen Thi Hoang Mai; Pham Thi Le Hoa; Nguyen Ba Thang; Van The Trung
Journal:  BMC Infect Dis       Date:  2017-04-26       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.